产品
编 号：F545536
分子式：C181H291N55O51S2.C2H4O2.xH2O
分子式：C181H291N55O51S2.C2H4O2.xH2O
产品类型
规格
价格
是否有货
结构图
CAS No: 99294-94-7
产品详情
生物活性：
Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PTH1 receptor agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research.
体内研究：
Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity.Animal Model:Female New Zealand white rabbits
Dosage:20 μg/kg
Administration:Subcutaneous injection; daily, for 4 weeks
Result:Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD).
Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) is a PTH1 receptor agonist. Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) can be used for osteoporosis research.
体内研究：
Teriparatide acetate hydrate (Human parathyroid hormone-(1-34) acetate hydrate) (20 μg/kg, i.h.; daily, for 4 weeks; female New Zealand white rabbits) increases the cortical thickness and porosity.Animal Model:Female New Zealand white rabbits
Dosage:20 μg/kg
Administration:Subcutaneous injection; daily, for 4 weeks
Result:Increased the pore ratio, number, and density as well as the cortical area, thickness, and bone mineral content (BMC), without significant influencing the volumetric bone mineral density (BMD).
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备